Clinical Trials Browser

Recurrence × trastuzumab deruxtecan × 90 days × Clear all

NCT07340164 2026-04-20

TROY

Phase 2 Recruiting

Ovarian Neoplasms, Recurrence

NCT07015697 2026-03-20

A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

Phase 1 Recruiting

Recurrence